![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2 Subunit Specificity of Cyclothiazide Inhibition on Glycine ReceptorsInstitute of Neuroscience and State Key Laboratory of Neuroscience, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China (X.-B.Z., G.-C.S., L.-Y.L., F.Y., T.-L.X.); and School of Life Sciences, University of Science and Technology of China, Hefei, China (X.-B.Z., T.-L.X.)
In the mammalian cortex,
2 subunit-containing glycine receptors (GlyRs) mediate tonic inhibition, but the precise functional role of this type of GlyRs is difficult to establish because of the lack of subtype-selective antagonist. In this study, we found that cyclothiazide (CTZ), an epileptogenic agent, potently inhibited GlyR-mediated current (IGly) in cultured rat hippocampal neurons. The inhibition was glycine concentration-dependent, suggesting a competitive mechanism. Note that GlyRs containing the
2 but not
1 or
3 subunits, when being heterologously expressed in human embryonic kidney 293T cells, were inhibited by CTZ, indicating subunit specificity of CTZ action. In addition, the degree of CTZ inhibition on IGly in rat spinal neurons declined with time in culture, in parallel with a decline of
2 subunit expression, which is known to occur during spinal cord development. Furthermore, site-directed mutagenesis indicates that a single-amino acid threonine at position 59 near the N terminus of the
2 subunit confers the specificity of CTZ action. Thus, CTZ is a potent and selective inhibitor of
2-GlyRs, and threonine at position 59 plays a critical role in the susceptibility of GlyR to CTZ inhibition.
Address correspondence to: Tian-Le Xu, Institute of Neuroscience, Chinese Academy of Sciences, 320 Yue-yang Road, Shanghai 200031, China. E-mail: tlxu{at}ion.ac.cnu